4Barnes PJ. Scientific rationale for inhaled combination therapy with long-acting beta 2- agonists and corticosteroids [ J ]. Eur Respir J, 2002, 19 ( 1 ) :182-191.
5Shapiro G, Lumry W,Wolfe J, Given J, White MV, Woodring A, et al. Combined salmeterol 50 microg and fluticasone propionate 250 microg in the diskus device for the treatment of asthma [ J ]. Am J Respir Crit Care Med, 2000, 161 (2 Pt 1) :527-534.
3JENKINS C,WOOLCOCK A J,SAARELAINEN P,et al.Salmetero/ fluticasone propionate combination therapy 50/ 250 microg twice daily is more effective than budesonide 800 microg twice daily in treating moderate to severe asthma[J].Respir Med,2000,94(7):715-723.
4JUNIPER E F,JENKINS C,PRICE M J,et al.Impact of inhaled salmetero/ fluticasone propionate combination product versus budesonide on the herlth-ralated quality of life of patients with asthma[J].Am J Respir Med,2002,1(6):435-440.
5MASOLI M.Global Initiative for Asthma[M].USA:GINA,2004.
6KIPS J C,O'CONNOR B J,INMAN M D,et al.A long-term study of the antinflammatory effect of low-dose budesonide plus for-moterol versus high-dose budesonide in asthma[J].Am J Respir Crit Care Med,2000,161(3Pt1):996-1001.
7EICKELBERG O,RHTH M,LORX R,et al.Ligand-independent activation of the glucocorticoid receptor by beta2-adrenergic receptor agonists in primary human lung fibroblasts and vascular smooth muscle cells[J].J Biol Mol Chem,1999,274(2):1005-1010.
8DOWLING R B,JOHNSON M,COLE P J,et al.Effect of salmeterol on haemophilus influenzae infection of respiratory mucosa in vitro[J].Eur Respir J,1998,11(1):86-90.
9DOWLING R B,JNHNSON M,COLE P J,et al.Effect of fluticasone propionate and salmeterolon pseudomonas aeruginosa infection of the respiratory mucosa in vitro[J].Eur Respir,1999,14(2):363-369.
10Muller GA,Eigen H.Pediatric pulmonary function testing in asthma[J] .J Pediatr Clin North Am,1992,39(6):1243-1258.
